vinorelbine

The drug is used as monotherapy for patients with metastatic breast cancer (Stage IV) if previous chemotherapy has been ineffective or is unsuitable, as well as for the treatment of Stage III and IV non-small cell lung cancer.

Form: concentrate for infusion solution

ATC: L01CA04

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (packaging, labelling and batch release)

The drug is used for the treatment of non-small cell lung cancer (stages 3–4), as well as for the treatment of metastatic breast cancer (stage 4) in cases where other methods of therapy have failed or are not possible.

Form: concentrate for infusion solution

ATC: L01CA04

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is indicated for adults for the treatment of non-small cell lung cancer (stage III or IV), as well as for advanced stage III or IV breast cancer that has recurred after ineffective anthracycline chemotherapy.

Form: concentrate for infusion solution

ATC: L01CA04

Manufacturer: Accord Healthcare Limited (additional secondary packaging)

The drug is used for the treatment of non-small cell lung cancer (stage 3 or 4), as well as for the therapy of metastatic breast cancer stage 3 or 4, if previous treatment with anthracyclines has been ineffective or if a relapse has occurred.

Form: concentrate for infusion solution

ATC: L01CA04

Manufacturer: Actavis Italia S.p.A.